Very few studies have examined the possibility whether HER-2/neu status can help discriminate aetiologically distinct subgroups of breast cancer cases, and none of them has identified the effect of increased BMI with HER-2/neu positive tumours [3,5,7-9]. Here, ERBB2 is linked to breast carcinoma.